Overview

Price chart · mood · technical indicators

RDNT

RadNet Incstock Healthcare

Diagnostics & Research

$51.8710.68%Current Market Mood:Strong Bearish

Market Mood

Price Range (1Y)

$50.76$85.84

Current: $51.87

Idea: SMA

1Y Return

+10.7%

Sharpe 3Y

0.78

Market Comparison

vs Healthcare Sector & Diagnostics & Research Industry

RDNT

-10.68%

1Y Performance

Healthcare

Sector 1Y

Diagnostics & Research

Industry 1Y

Fundamentals

Updated daily after market close

P/E ratio—Forward 36.63

EPS (TTM)$-0.1775.0% YoY

Profit margin-0.7%HEALTHCARE

Market cap$4.08BMid cap

Wall Street coverage

$89.75median target· current $61.05 (+47.0%)8 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E: 36.63
PEG ratio: 0.96
P/B: 3.77
P/S (TTM): 1.90
EV/EBITDA: 17.15

Profitability & growth

ROE (TTM): 1.8%
Operating margin: -2.9%
Revenue growth YoY: 22.1%
Dividend yield: —
Beta: 1.43

Last earnings

May 11, 2026 · Estimate $-0.19 · Reported $-0.28

Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

50 articles · sorted by date

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About RadNet Inc

Company profile

RadNet, Inc., provides outpatient imaging services in the United States. The company is headquartered in Los Angeles, California.

Classification

Sector: Healthcare
Industry: Diagnostics & Research
Exchange: NASDAQ
Country: USA
Currency: USD

Company profile

HQ: 1510 COTNER AVENUE, LOS ANGELES, CA
Fiscal year end: December
Latest quarter: Mar 31, 2026

Market cap$4.08B

Shares outstanding$78.6M

52W high$85.84

52W low$50.76

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer

Overview

RDNT

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

RadNet (RDNT) investors back all 2026 meeting items, including pay and equity plan

RadNet seeks $200 million incremental term loan for growth

RadNet seeks to secure $200M term loan to fuel expansion

RadNet (RDNT) director receives 2,946-share common stock award grant

RadNet (RDNT) director Gregory Spurlock receives 2,946-share stock award

RadNet seeks $200M loan to support growth

RadNet Announces Plans for $200 Million Incremental Term Loan to Fund Acquisitions and Expansion

RadNet (NASDAQ: RDNT) seeks $200M term loan to fund expansion

RadNet seeks $200M incremental term loan to fund acquisitions, expansion

RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities

Alpha Wave Global Reduces RadNet Stake, According to Recent SEC Filing

Alpha Wave Global Reduces RadNet Stake, According to Recent SEC Filing

Do Options Traders Know Something About RadNet Stock We Don't?

Barclays Lowers RadNet (RDNT) Price Target, Says Imaging Business Continues to Outperform

Barclays Lowers RadNet (RDNT) Price Target, Says Imaging Business Continues to Outperform

RadNet to Host Men's Health Webinar on June 13, 2026

Free webinar tackles heart disease and cancer risks for men

RadNet to Host Men's Health Webinar on June 13, 2026

Barclays Maintains RadNet(RDNT.US) With Buy Rating, Cuts Target Price to $65

RadNet Is Maintained at Overweight by Barclays

About RadNet Inc

Classification

Company profile

RDNT

Market Comparison

RDNT Market Analysis

Overview

RDNT

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

RadNet (RDNT) investors back all 2026 meeting items, including pay and equity plan

RadNet seeks $200 million incremental term loan for growth

RadNet seeks to secure $200M term loan to fuel expansion

RadNet (RDNT) director receives 2,946-share common stock award grant

RadNet (RDNT) director Gregory Spurlock receives 2,946-share stock award

RadNet seeks $200M loan to support growth

RadNet Announces Plans for $200 Million Incremental Term Loan to Fund Acquisitions and Expansion

RadNet (NASDAQ: RDNT) seeks $200M term loan to fund expansion

RadNet seeks $200M incremental term loan to fund acquisitions, expansion

RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities

Alpha Wave Global Reduces RadNet Stake, According to Recent SEC Filing

Alpha Wave Global Reduces RadNet Stake, According to Recent SEC Filing

Do Options Traders Know Something About RadNet Stock We Don't?

Barclays Lowers RadNet (RDNT) Price Target, Says Imaging Business Continues to Outperform

Barclays Lowers RadNet (RDNT) Price Target, Says Imaging Business Continues to Outperform

RadNet to Host Men's Health Webinar on June 13, 2026

Free webinar tackles heart disease and cancer risks for men

RadNet to Host Men's Health Webinar on June 13, 2026

Barclays Maintains RadNet(RDNT.US) With Buy Rating, Cuts Target Price to $65

RadNet Is Maintained at Overweight by Barclays

About RadNet Inc

Classification

Company profile

RDNT

Market Comparison